Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil

Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis

(2009) Walther J. van Venrooij et al.   Annals of the New York Academy of Sciences

Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions

(2009) Kari Hemminki et al.   ARTHRITIS AND RHEUMATISM

The preclinical stages of RA: lessons from human studies and animal models

(2009) Hani El-Gabalawy   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Sex differences in rheumatoid arthritis: more than meets the eye...

(2009) Ronald F van Vollenhoven   BMC Medicine

Immunogenetic Risks of Anti-Cyclical Citrullinated Peptide Antibodies in a North American Native Population with Rheumatoid Arthritis and Their First-degree Relatives

(2009) H. S. El-GABALAWY et al.   JOURNAL OF RHEUMATOLOGY

Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis

(2008) D M Lee et al.   ANNALS OF THE RHEUMATIC DISEASES

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

(2008) Andreea Ioan-Facsinay et al.   ARTHRITIS AND RHEUMATISM

Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis

(2008) Adriana Rojas-Villarraga et al.   JOURNAL OF AUTOIMMUNITY